Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Oncology Clinical Trials
100%
Cancer Clinical Trials
60%
Overall Survival
36%
Oncology
30%
Randomized Clinical Trial
26%
Randomized Phase III Trial
23%
Meta-epidemiological Study
22%
Clinical Trials
20%
Cooperative Group
19%
Stereotactic Body Radiation Therapy
18%
Control Arm
17%
95% Confidence Interval
17%
Treatment Effect
16%
Local Therapy
16%
Phase II Trial
16%
Age Disparity
15%
Epidemiological Analysis
15%
Oncologic
15%
Hazard Ratio
15%
Randomized Controlled Trial
14%
Radiotherapy
14%
Metastatic Tumor
14%
Multivariable
13%
Surrogate Endpoint
12%
Clinical Trial Participant
11%
In Cancer
11%
Statistical Significance
11%
Head-and-neck Cancer
10%
Patient Outcomes
10%
Odds Ratio
10%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
10%
Progression-free Survival
10%
Exclusion Criteria
10%
Trial Results
10%
Suboptimal Control
10%
Radiomics
10%
Metastatic Pancreatic Cancer
10%
Ewing Sarcoma
10%
In Silico
10%
Interim Analysis
10%
Systemic Therapy
9%
Cooperative Group Trial
9%
Industry-funded
9%
Trial Design
7%
Subgroup Analysis
7%
Radiation Therapy
7%
Quality of Life
7%
Non-inferiority Trial
7%
Posterior Probability
6%
Clinically Significant
6%
Medicine and Dentistry
Oncology
94%
Clinical Trial
90%
Malignant Neoplasm
60%
Arm
39%
Overall Survival
36%
Radiation Therapy
32%
Randomized Clinical Trials
29%
Randomized Controlled Trial
22%
Odds Ratio
21%
Stereotactic Body Radiation Therapy
17%
Local Therapy
16%
Treatment Effect
16%
Solid Malignant Neoplasm
15%
Diseases
15%
Pancreas Cancer
15%
Systemic Therapy
13%
Hazard Ratio
12%
Quality of Life
12%
Phase III Trials
11%
Cross Sectional Study
10%
Progression Free Survival
10%
Oropharynx Carcinoma
10%
Hepatocellular Carcinoma
10%
Liver Transplantation
10%
Ewing Sarcoma
10%
In Silico
10%
Interim Analysis
10%
Chemotherapy
8%
Patient-Reported Outcome
7%
Cancer
6%
Prevalence
6%
Breast Cancer
6%
Logistic Regression Analysis
6%
Therapy Effect
5%
Subgroup Analysis
5%
Xerostomia
5%
Neoplasm
5%
Neoadjuvant Chemotherapy
5%
Head and Neck Cancer
5%
Exclusion Criterion
5%
Lung Cancer
5%
Reproducibility
5%
Biological Marker
5%
Wart Virus
5%
positron emission tomographic scan
5%
English (Language)
5%
Racial Disparity
5%
Adaptive Radiotherapy
5%
Oropharynx Squamous Cell Carcinoma
5%
Pancoast Tumor
5%
